ESTRO 2024 - Abstract Book

S1828

Clinical - Lung

ESTRO 2024

Conclusion:

This clinical trial shows that moderately Hypo-RT using HT improves the OS in patients with unresectable stage III

NSCLC, with similar toxicity rates compared with Con-RT.

Keywords: NSCLC,helical tomotherapy (HT),chemoradiotherapy